Announcements Trials
Browse Landscape

Phase

Phase 1 17Phase 2 13Phase 3 12Phase NA 2Phase 1/2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 325Uterine Cervical Neoplasms 131Endometrial Neoplasms 109Breast Neoplasms 99Carcinoma, Non-Small-Cell Lung 85Fallopian Tube Neoplasms 77Colorectal Neoplasms 74Carcinoma, Ovarian Epithelial 71Neoplasms 63Pancreatic Neoplasms 62Stomach Neoplasms 59Melanoma 57Neoplasm Metastasis 51Triple Negative Breast Neoplasms 49Squamous Cell Carcinoma of Head and Neck 43Prostatic Neoplasms 42Lung Neoplasms 41Esophageal Neoplasms 40Head and Neck Neoplasms 39Urinary Bladder Neoplasms 32Carcinoma, Renal Cell 31Sarcoma 29Recurrence 28Small Cell Lung Carcinoma 26Colonic Neoplasms 25Carcinoma, Hepatocellular 24Carcinoma, Transitional Cell 20Uterine Neoplasms 16Peritoneal Neoplasms 15Mesothelioma 15

Interventions

pegfilgrastim 1X-Rays 1Specimen Handling 1Mesenchymal Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Erlotinib Hydrochloride 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Brenner Tumor × Gynecologic × Clear all
NCT02068794 2025-11-18

MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Mayo Clinic

Phase 1/2 Active not recruiting
34 enrolled 12 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00217529 2010-09-21

Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡